Turnhout, Belgium

Gaston Stanislas M Diels

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaston Stanislas M Diels. Retrieved from https://idiyas.com/inventor/gaston-stanislas-m-diels

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gaston Stanislas M Diels: Innovator in MALT1 Inhibition

Introduction

Gaston Stanislas M Diels is a notable inventor based in Turnhout, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways.

Latest Patents

Diels holds a patent for "Pyridine rings containing derivatives as MALT1 inhibitors." This patent discloses compounds, compositions, and methods for treating diseases, syndromes, conditions, and disorders that are influenced by the modulation of MALT1. The compounds are represented by a specific formula, with variables defined within the patent documentation. He has 1 patent to his name.

Career Highlights

Diels is associated with Janssen Pharmaceutica NV, a prominent company in the pharmaceutical industry. His work focuses on innovative solutions for complex health issues, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Diels has collaborated with esteemed colleagues, including Johannes Wilhelmus J Thuring and Tianbao Lu. These partnerships have contributed to the development of groundbreaking research and innovative therapeutic approaches.

Conclusion

Gaston Stanislas M Diels exemplifies the spirit of innovation in the pharmaceutical field, particularly through his work on MALT1 inhibitors. His contributions continue to impact the landscape of medicinal chemistry and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…